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Sexually transmitted diseases (STDs) are epidemic in
developing countries including South Africa, and the challenge
of STD control in these settings is immense l The World Health
Organisation (WHO) estimates that more than 300 million
curable STDs occur each year - and this does not account for
the millions of viral infections that also occur. Not only are
STDs unpleasant acute illnesses, they may also lead to chronic
sequelae, including infertility and ectopic pregnancy, and to
death. Furthermore, STDs are associated with increased risk of
HIV transmission.' Improved STD treatment services have been
associated with reduced HIV incidence in at least one setting;
and STD control is a core HIV control strategy.' The issue is:
how can STD treatment services be expanded and improved to
achieve a wide-scale public health impact?
To date, much of the literature on STD control in developing
countries has focused on the public health sector and its
important role. The public sector comprises government-
funded health services, and STD treatment services are a
traditional part of the core public sector package,s either as
dedicated 'STD clinics', or more recently, integrated into more
comprehensive reproductive health or primary care services.
As health sector reform takes hold of health services in
developing countries,s STD treatment services are becoming
more integrated into the comprehensive district health system.
There are, however, other health servic", prOViders, such as the
private medical sector, occupational health services, and the
traditional health care sector, that need to be considered. But
little is known about their roles in STD control in developing
countries.
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The private sector, primarily fee-for-service doctors but also
pharmacies, is extensive throughout much of the developing
world. Indeed, in many settings where public sector services
are struggling to recruit and retain staff, the private sector may
be thriving. Many patients prefer a private doctor or a
pharmacy to a public clinic for some complaints, but how
many, why, when, and at what cost, is not fully understood,
especially with regard to STDs' Furthermore, what is the
quality of these services? Through a series of visits to
pharmacies by standardised simulated patients in Peru it was
learnt that treatments offered rarely conformed with national
guidelines.'
Of course, some 'health services' are more effectively
delivered outside the public health system. Family planning
services may be delivered more effectively through non-
governmental organisations, local clubs and social marketing.
Many patients with a variety of illnesses choose to self-
medicate, frequently with therapies bought 'over the counter'
either in a pharmacy or the market.
Thus, the public sector does not have a monopoly on
providing STD treatment services. It seems unlikely that the
goal of STD control with measurable public health impact will
be achieved by the public sector alone. What are the obstacles
to, and opportunities for, effective public-private sector
interaction for STD control in developing countries? We report
the lessons learnt from a project in rural South Africa, consider
the generic issues that we faced, and make some
recommendations. Here, we focus on the interaction between
the public service and the private medical sector, while
recognising the importance of other sectors.
HLABISA PRIVATE SECTOR STUDY -
OBSTACLES TO STD CONTROL
Hlabisa health district serves approximately 210 000 largely
Zulu-speaking people in the province of KwaZulu-Natal. In
many ways it is a typical district: partly urbanised but largely
rural; largely under-resourced, especially with regard to health
services; and the social structure is dominated by large-scale
migration of men to major cities in search of work. STDs are
highly prevalent - we estimate that 25% of women of
reproductive age have at least one STD on any given day." The
HIV epidemic in the area is explosive, with the prevalence
among pregnant women having increased from 4.2% in 19929
to 41.2% at the end of 1998. The district is served by a district
hospital and 12 public sector primary care clinics, and 11
doctors in private practice. An STD syndrome surveillance
system that we established in the public and private health
sectors of the district indicated that approximately half of all
STDs are treated by private doctors. lo Pharmacists do not treat
STDs in South Africa, and antibiotics are not available over the
counter or in the markets.
Inadequate treatment in the private sector
Having established the surveillan<;:e system,'· we studied the
prescribing habits of the 11 doctors for three major STD
syndromes (male discharge, genital ulcer disease, and pelvic
inflammatory disease). None of 33 prescriptions written"
matched those recommended by the provincial Health
Department, and only 9% were judged likely to be adequate
therapy. Although most doctors reported supplying condoms,
and several reported counselling patients, none provided
partner treatment cards or written health education," indicating
that comprehensive syndrome management was not being
practised.
Inadequate treatment in the public sector
We also documented poor quality STD services in the public
sector clinics in Hlabisa;12 only 9% of simulated patients
received comprehensive syndromic management (drugs,
condoms, partner cards and health education), and 41%
received correct drugs. In response, we designed and piloted
STD syndrome packets," which together with a simple health
worker training intervention were successfully introduced into
the clinics. A substantial increase in the quality of treatment
provided was observed. I' one of this was possible with the
private doctors; instead we faced numerous obstacles (Table I).
Table I. Obstacles to improving STD treatment services in the
private sector
• lndividual doctors in competition with each other - little
opportunity to bring them together to share experience and
to develop solutions to problems
• Little history of public-private sector interactions other than
passive referral of cases from private practitioners to public
hospitals
• Resistance to change - strong ethos of individual
practitioner as decision-maker
• Economics as the main force determining practice patterns
• No approval from authorities to dispense drugs bought
through public sector mechanisms through the private sector
• Little interest in using STD syndrome packets and packing
own drugs
Obstacles in the private sector
Firstly, the 11 doctors we worked with are all in competition
with each other. For example, there is no co-operation over
matters of shared concern such as after hours emergency
service provision. This meant that project staff had to make
repeated individual calls to each doctor to gain suppod for the
study, to encourage participation in the surveillance system,
and to develop and pilot an intervention. When we arranged
project workshops or meetings, few doctors could find the time
to attend.
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In contrast with the public sector nurses we worked with,
private doctors displayed substantial resistance to change. This
was frequently expressed as 'professional and therapeutic
independence', with the doctors believing that they are best
placed to make an informed decision about the best therapy for
an individual patient. It became clear that these therapeutic
decisions were influenced by the desire to prioritise
inexpensive therapy over effective therapy.n For example,
penicillin was often given for male discharge. Most treatment
given was inadequate because it was of low dose, given for too
short duration, or was the wrong (cheap) drug." Most doctors
did not agree, in principle, with the strategy of syndromic
management of STDs (although they actually practised it by
frequently giving several different drugs for one syndrome) or
of standardised treatment protocols provided by national or
provincial health authorities.
A recurring theme in our interaction with the private doctors
was the economics of care. By definition, private practitioners
make their living directly from their clients, and it would only
be reasonable for the economic aspects of providing a service to
be high on their agenda. Indeed, many would argue for a more
cost-conscious approach in the public sector where waste and
inefficiency can frequently be much higher than any private
practitioner would tolerate. However, our experience was that
the cost, and hence the profit margin of providing a service,
took precedence over other considerations in any discussion
about restructuring therapeutic decisions. Although we
estimated that average profit would have fallen by
approximately 25% if provincially recommended treatment
regimens had been adopted, it might well have been possible
to pass the increase in drug costs on to the client. Indeed, if
drugs could be made available to the private sector at state
tender prices, profits would actually have increased 10 - 25%."
Thus, there is at least the potential to provide effective STD
treatment in the private sector without removing financial
incentives.
Finally, having achieved only limited success with the STD
syndrome packets" given to the doctor, the project was
abandoned for two main reasons. First, it was clear that
changing their therapeutic decisions about STD treatment was
going to be very difficult, and secondly we experienced
difficulty in getting the authorities to allow drugs bought
through the state system to be dispensed by private
practitioners, even on a pilot basis. What was also
disappointing was that despite initial enthusiasm for the
syndrome packets, few doctors were interested in our offer to
provide them with the packets, including condoms, partner
notification cards and a patient information leaflet, into which
they could pack their own drugs.
What are the generic issues that arise from this experience,
and that may be applicable in other settings?
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OPPORTUNITIES FOR STD CONTROL
Community STD control is ultimately a government
responsibility. It seems clear that while the public health system
is a critical component in achieving this, private sector co-
operation is also needed for there to be any chance of success.
Put simply, in the Hlabisa district, even if all patients attending
the public sector were correctly treated, but a similar number
attending the private sector are incorrectly treated, the net
public health benefit is likely to be small, and of limited
duration. A partnership with an effective private sector must be
forged (Table IT).
Table 11. Opportunities for STD control, through and with the
private sector
• Private medical sector treats a large proportion of patients
with STDs, and must be involved in STD control strategies
• Private sector must be organised
• Representatives should be involved in policy setting process
• Representatives should be involved in developing standard
treatment guidelines
• Structured, continuing medical education needed
• System of re-accreditation should be considered
• Formally involve private sector in the district health system
• Use public sector purchasing power (e.g. vaccines and
essential drugs) to strengthen components of private
practice that have a key public health function or impact,
e.g. STD, TB, vaccine-preventable diseases
Setting policy and standards is a government function, and
as such it is often easier to apply changes to policy in the public
sector - we certainly found it much easier to introduce
changes in the public sector. Unless private practitioners are
involved in policy setting and in developing treatment
guidelines, it seems unlikely that they will embrace them,
especially if a change in current practice is required. However,
unless the private sector can organise itself and speak with a
coherent voice, how can it be effectively involved in policy
setting? In countries that do not require formal postgraduate
training to enter general practice independently, academic
institutes and professional organisations are unlikely to speak
for most of the profession. In South Africa, a formal system of
continuing medicai education and of regular re-accreditation is
being developed in the hope that this will further improve
standards.
What right or responsibility do public sector authorities have
to measure standards in the private sector, when public sector
standards may also be poor? If the public sector can lead by
example, and provide an accessible, quality and effective
service, then the private sector will have to follow suit, as
satisfied clients are likely to be attracted to the public services.
As comprehensive district health services evolve in South
Africa and elsewhere, there may be an expanded opportunity
to involve the private medical sector in delivering public health
programmes. For example, although immunisation services are
typically a public sector activity, missed opportunities could be
reduced if private doctors were supplied with vaccines by the
public sector. This already happens informally in many parts of
South Africa. If the necessary controls are put in place, this
could also be extended to certain drugs. Perhaps drugs listed in
a national formulary could be made available to private
doctors at state tender prices, for treatment of specific
conditions. This could offer the opportunity for expanded
access to essential services, and if linked to medical education,
quality of care might also improve.
The public sector seems to be good at producing evidence-
based policies for public health benefit, but it frequently
struggles to implement policy effectively. The private sector,
however, can be very good at packaging, promoting and
delivering many services. If key restrictive barriers can be
broken down, there may be an opportunity to form a
partnership between public and private sectors and hence
improve STD control.
RECOMMENDATIONS
More research is needed to define further the role of the
different health sectors in STD treatment and control activities
in South Africa. Standard tools and methods for assessing
service quality are available.'·12 Private practitioners should
ideally be willing partners in this research.
If the quality of services in the private or the public sector is
found to be wanting, effective mechanisms for change need to
be developed. Our experience suggests that while useful
research can be done locally, change is unlikely to occur
without attention to significant structural issues that typically
exist at provincial and national level. Potential mechanisms for
change are listed below.
Legislation
In South Africa, the restruLturing of the health sector has been
accompanied by major legislative change. Although frequently
not popular, this approach has had the effect of forcing the pace
of change. While legislation on periodic re-accreditation of
doctors is unpopular, it offers an opportunity to improve and
assess standards of therapy formally. The structured continuing
education required of a re-accreditation process offers an
important opportunity to ensure that practitioners stay up to
date.
Incentives
Financial incentives may offer an important opportunity for
change. It may be possible to pay some, or all, private
practitioners in an area to provide certain services on behalf of
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the public sector. This might include STD treatment, for
example. If the local or provincial government is paying for a
service, it has the right to ensure that the service is of
acceptable standard? Other options include making STD drugs
or STD syndrome packets available to the private sector at state
tender prices. There is always a risk of abuse, but with correct
organisation and auditing, abuse could be minimised.
Education
Education of doctors and other health workers needs to start
with the undergraduate curriculum. Education needs to
continue through specialist and postgraduate training, and also
to be complemented by a programme of continuing medical
education thereafter. Today's health worker needs to
understand the value of evidence-based medicine, standard
treatment guidelines, and structured approaches to care.
CONCLUSION
STD control must remain a high priority for South Africa.
Achieving control is unlikely if the public sector acts alone.!'
Many patients seek care in the private medical sector and an
effective partnership between it and the public sector needs to
be forged. While quality of services can be assessed locally, it
seems likely that effective change will only occur within a
framework of legislation, financial incentives and continuing
education.
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CORTICAL LENS OPACITIES IN THE
YOUNG PATIENT - AN
INDICATION FOR A LIPOGRAM?
D Meyer, F J Maritz, P H Liebenberg, D P Parkin, L J Burgess
Aim. To determine the characteristics and prevalence of
lenticular opacification in patients·with underlying
dyslipidaemia.
Methods. Eighty patients of both genders and all ages
(18 - 90 years) were enrolled in the trial if they met the
inclusion criteria for dyslipidaemia:
Patients were included if their fasting serum cholesterol
and triglyceride concentrations were> 5.2 mmol/l and
> 2.3 mmol/l, respectively, when measured on three
separate occasions over a I-month period.
Patients were excluded if they suffered from any
condition known to cause or predispose them to elevated
lipid levels or lenticular opacification. Lenticular changes
were assessed by means of a slit-lamp through the fully
dilated pupil and other physical signs were documented
subsequent to thorough physical evaluation.
Results. In addition to the classic clinic signs of
dyslipidaemia, 31% of patients had cortical lens opacities.
Cortical opacities were twice as prevalent as Achilles
tendon thickening (16.3%) in our study, the second most
prevalent sign of elevated lipid levels. In the subgroup of
patients aged under 50 years, 55% had lenticular opacities,
predominantly cortical (80%).
Conclusions. Cortical lens opacification was the most
prevalent sign of dyslipidaemia and it occurred at a
relatively young age in our trial population in those
patients who were affected. Cortical lenticular opacification
should be regarded as an indication for blood lipid profile
evaluation.
S AfT Med J2001; 91: 520-524.
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